ACE inhibitors can induce circulating antibodies directed to antigens of the superficial epidermal cells

[1]  山上 淳.  Antibodies to the desmoglein 1 precursor proprotein but not to the mature cell surface protein cloned from individuals without pemphigus , 2010 .

[2]  M. Amagai,et al.  Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence. , 2009, The Journal of investigative dermatology.

[3]  Preety M. Sharma,et al.  Pathogenic anti-desmoglein MAbs show variable ELISA activity because of preferential binding of mature versus proprotein isoforms of desmoglein 3. , 2009, The Journal of investigative dermatology.

[4]  N. Cirillo,et al.  High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes. , 2009, Immunology letters.

[5]  M. Hertl,et al.  IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris , 2007, Experimental dermatology.

[6]  Jean Kanitakis,et al.  Comparative study of indirect immunofluorescence and immunoblotting for the diagnosis of autoimmune pemphigus , 2004, Archives of Dermatological Research.

[7]  T. Krieg,et al.  Linear IgA bullous dermatosis induced by atorvastatin. , 2001, Journal of the American Academy of Dermatology.

[8]  E. Ruocco,et al.  In vivo Enalapril-Induced Acantholysis , 1999, Dermatology.

[9]  Komai,et al.  Usefulness of enzyme‐linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus , 1999, The British journal of dermatology.

[10]  J. Bystryn,et al.  Sensitivity of indirect immunofluorescence, substrate specificity, and immunoblotting in the diagnosis of pemphigus. , 1997, Journal of the American Academy of Dermatology.

[11]  S. Muller,et al.  Angiotensin-converting enzyme inhibitor-induced pemphigus: three case reports and literature review. , 1994, Mayo Clinic proceedings.

[12]  R. Wolf,et al.  Drug-induced pemphigus. I. A survey. , 1993, Clinics in dermatology.

[13]  V. Ruocco,et al.  ENALAPRIL: A POWERFUL IN VITRO NON‐THIOL ACANTHOLYTIC AGENT , 1992, International journal of dermatology.

[14]  R. Kaplan,et al.  Drug-induced pemphigus related to angiotensin-converting enzyme inhibitors. , 1992, Journal of the American Academy of Dermatology.

[15]  J. Zone,et al.  Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. , 1991, The Journal of investigative dermatology.

[16]  V. Ruocco,et al.  Biochemical acantholysis provoked by thiol drugs. , 1990, Archives of dermatology.

[17]  D. Mutasim,et al.  Drug-induced pemphigus. , 1993, Dermatologic clinics.

[18]  A. Hood,et al.  Induction of acantholysis in organ explant culture by penicillamine and captopril. , 1989, Archives of dermatology.

[19]  H. Su,et al.  Comparative expression of bullous pemphigoid antigens in normal human epidermis and cultured keratinocytes. , 1989, Clinical immunology and immunopathology.

[20]  V. Ruocco,et al.  In vitro acantholysis by captopril and thiopronine. , 1988, Dermatologica.

[21]  V. Ruocco,et al.  Drug-induced pemphigus. , 1998, Clinics in dermatology.

[22]  J. Chapuis,et al.  [Pemphigus induced by treatment with a propanolol-meprobamate combination]. , 1980, Annales de dermatologie et de venereologie.